Launched iFlash 1200 the smallest model of iFlash  Family

IPO Listed on SSE (Shanghai Stock Exchange)

Launched  CLIA Assays for SARS-CoV-2

Launched iModules Modular System

Awarded “Top Innovative Enterprises in Shenzhen”

Won the prize of “Innovation Star Cup for Excellent Reagent”

Awarded “Enterprise with Intellectual Property Advantages”

Launched VISION Pro, the ESR analyzer

Headquarters moved in YHLO Biopark

Launched iFlash 1800 (Bench-top CLIA) and UNICELL POCT System

Awarded “China Most Investment Valuable Brand in IVD Field”

Dr. Frank, YHLO’s chief scientist—— "Lifetime Honorary Award of China IVD Industry Leader”

Inhibin B won the first prize of “Innovative Star Cup”

Launched iFlash 3000, China’s first high throughput CLIA analyzer

Received Europe/US patents for VISION

AMH won the third prize of “Innovative Star Cup”

Launched VISION, China’s first ESR analyzer with EDTA tubes direct test

Received ISO 13485 certificate

Launched Tenfly immunoblot systems

Awarded “National High-Tech Enterprise”

Launched UNION, China’s first monotest immunology analyzer

Received ISO 9001 certificate

Awarded “Shenzhen High-Tech Enterprise”

Launched autoimmune assays

Established Europe R&D office

Established YHLO Biotech, specialized in immunoassay

Distribution of IVD products through the trading company